欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/V/0289/001
药品名称Bravoxin suspension for injection for cattle and sheep
活性成分
    • clostridium perfringens A 1.0 U
剂型Suspension for injection
上市许可持有人Intervet International B.V. Wim de Körverstraat 35 5831 AN Boxmeer Netherlands
参考成员国 - 产品名称Germany (DE)
Bovilis Bravoxin 10
互认成员国 - 产品名称
    • Portugal (PT)
    • Bulgaria (BG)
    • Denmark (DK)
      Tribovax Vet.
    • Italy (IT)
    • Cyprus (CY)
    • Belgium (BE)
      Bravoxin
    • Greece (GR)
    • Czechia (CZ)
      Bravoxin injekční suspenze pro skot a ovce
    • Netherlands (NL)
    • Sweden (SE)
    • Romania (RO)
    • Luxembourg (LU)
    • Norway (NO)
      Ovilis Tribovax 10 vet.
    • Slovakia (SK)
    • Iceland (IS)
      Tribovax vet.
    • Finland (FI)
    • Croatia (HR)
    • United Kingdom (Northern Ireland) (XI)
    • Poland (PL)
    • Ireland (IE)
    • Latvia (LV)
      Bravoxin suspensija injekcijām liellopiem un aitām
    • Austria (AT)
      Bravoxin Injektionssuspension für Rinder und Schafe
    • Lithuania (LT)
    • France (FR)
    • Estonia (EE)
    • Spain (ES)
    • Hungary (HU)
许可日期2020/12/16
最近更新日期2023/11/22
药物ATC编码
    • QI02AB01 clostridium
    • QI04AB01 clostridium
申请类型
  • TypeLevel1:food
  • TypeLevel2:Immunological
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase